- Report
- March 2025
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- December 2024
- 175 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- October 2024
- 205 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 244 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Book
- June 2012
- 412 Pages
Pharmaceutical Lifecycle Management (PLM) is a process used to manage the development of drugs from discovery to commercialization. It involves the coordination of activities across multiple departments, including research and development, manufacturing, regulatory affairs, and marketing. PLM helps to ensure that the drug is developed in a cost-effective and timely manner, while meeting regulatory requirements.
PLM begins with drug discovery, which involves the identification of potential drug candidates. This is followed by pre-clinical development, which involves testing the drug in laboratory and animal models. If the drug is found to be safe and effective, it can then move into clinical trials. During this phase, the drug is tested in humans to assess its safety and efficacy. If the drug is approved by regulatory authorities, it can then be manufactured and marketed.
Some companies in the PLM market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more